Angina patients with no obstructive CAD had no worse outcomes over 15 years, perhaps because they got the care they needed.

The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital.

The US Food and Drug Administration has approved the use of lerodalcibep (Lerochol) to reduce LDL cholesterol alongside ...

The match didn’t cause a “mismatch of supply and demand” but did reveal an opportunity to create change, experts say.

The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.

Understanding the athlete heart in light of normal aging and CV risk requires a nuanced look at imaging findings, the paper ...

It’s not yet known whether a fibroid diagnosis could enhance risk stratification or how best to prevent ASCVD in these ...

Survival, quality of life, and efficacy remained similar in the 3 years after TAVI for patients with versus without blockages ...

Panelists considered the technology relatively safe but weren’t swayed by the “statistical gymnastics” needed to find a ...

Among adults older adults, a respiratory syncytial virus (RSV) infection increases the risk of cardiovascular events over the ...

An analysis, though based on self-reported data, hints that ischemic drivers of HF carry less clout than they did 35 years ...

For people younger than 55 years, frailty’s consequences appear to be more severe and its drivers more apt to be ...